At Amaranth, we strive to develop the best in class bioresorbable scaffolds that rival metal drug eluting stents. Our unique polymer and proprietary technologies are used to create scaffolds that balance strength with flexibility for treating cardiovascular disease. Our most current scaffold, the sub-100 µm MAGNITUDE®, is the thinnest bioresorbable scaffold in clinical studies. MAGNITUDE®, built from the knowledge gained from FORTITUDE® and APTITUDE®, maintains the radial strength, expansion properties, and deliverability but with thinner struts and lower profile.
Amaranth Medical, Inc. began as a collaboration between Silicon Valley medical device expert, Kamal Ramzipoor, and two polymer scientists. Incorporated in 2005, Amaranth Medical, Inc. is supported by several noted international venture funds and corporations. The Company is headquartered in Mountain View, California, with additional operations in Singapore.